JESSICA GDOVIN: Open Payments
NPI 1528078912 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 24 payments from 12 companies in 2025. Trend: 2023 $803 · 2024 $472 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 6 | $143 |
| Astellas Pharma US Inc | 3 | $91 |
| Sage Therapeutics, LLC | 3 | $47 |
| Hologic Sales and Service, LLC | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Dexcom, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| MILLICENT US INC | 1 | $17 |
Products named: Veozah, ZURZUVAE, APTIMA, MYFEMBREE, Lynkuet, Mirena, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across NV — which companies pay providers there.
